PE-362 A Novel Clinical Indicator Using Tc-99m Sestamibi for Evaluating Cardiac Mitochondrial Function in Patients with Cardiomyopathies(Nuclear cardiology-5, The 71st Annual Scientific Meeting of the Japanese Circulation Society)

スポンサーリンク

概要

• 論文の詳細を見る
• 社団法人日本循環器学会の論文
• 2007-03-01

著者

• TSUTAMOTO Takayoshi

  Department of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science

• HORIE Minoru

  Department of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science

• Matsuo Shinro

  Department of Nuclear Medicine, Kanazawa University Hospital

• Masuda Daisuke

  Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine

• MITAMURA Hideo

  Saiseikai Central Hospital

• Matsumoto Tetsuya

  Department of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science

• Nakae Ichiro

  Department of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science

• Nagaoka Iori

  滋賀医科大学 呼吸循環器内科

• Nagaoka Iori

  Department Of Cardiovascular And Respiratory Medicine Shiga University Of Medical Science

• Matsuo S

  Department Of Nuclear Medicine Kanazawa University Hospital

• Matsuo Shinro

  滋賀医科大学 内科学第一

• Matsuo Shinro

  滋賀医科大学 呼吸循環器内科

• Matsuo Shinro

  Kanazawa Univ. Hospital Kanazawa Jpn

• Matsuo Shinro

  Department Of Nuclear Medicine Kanazawa University Hospital

• Matsuo Shinro

  Department Of Cardiovascular And Respiratory Medicine Shiga University Of Medical Science

• Matsuo Shinro

  日本大学 医学部循環器内科部門

• Matsumoto Tetsuya

  Cardiovascular And Heart Failure Center Kusatsu General Hospital

• Masuda Daisuke

  滋賀医科大学 呼吸循環器内科

• Masude Daisuke

  Department Of Cardiovascular And Respiratory Medicine

• Matsumoto Tetsuya

  Department Of Cardiovascular And Respiratory Medicine Shiga University Of Medical Science

• Nakae Ichiro

  Department Of Cardiovascular And Respiratory Medicine Shiga University Of Medical Science

• Masuda Daisuke

  Department Of Cardiovascular Medicine Kyoto University Graduate School Of Medicine

• Takahashi Masayuki

  Department Of Medicine Shiga University Of Medical Science

• Masuda Takuya

  First Department Of Internal Medicine Shiga University Of Medical Science

• Nakae Ichiro

  Department Of Internal Medicine Shiga University Of Medical Science

• Tsutamoto Takayoshi

  Cardiovascular And Respiratory Medicine Shiga University Of Medical Science

• Tsutamoto Takayoshi

  Department Of Cardiovascular And Respiratory Medicine

• Horie Minoru

  Department Of Cardiac Physiology National Cardiovascular Center Research Institute

• Nakae Ichiro

  Division Of Cardiology Internal Medicine Shiga University Of Medical Science

• Takahashi Masayuki

  Department Of Cardiovascular And Respiratory Medicine Shiga University Of Medical Science

• Matsuo Shinro

  Division Of Cardiology Department Of Medicine Shiga University Of Medical Science

• Matsui Toshiki

  First Department Of Internal Medicine Shiga University Of Medical Science

• Matsumoto Tetsuya

  Department Of Cardiovascular And Respiratory Medicine

• Takahashi Masayuki

  First Department Of Internal Medicine Shiga University Of Medical Science

• Matsuo Shinro

  滋賀医科大学 1内

• Takahashi Masayuki

  First Department Of Medicine Shiga University Of Medical Science

• MASUDA Daisuke

  Department of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science

関連論文

• Comparison of the long-term effects of candesartan and olmesartan on plasma angiotensin II and left ventricular mass index in patients with hypertension
• FRS-031 Additional Gene Modifiers Reduce Effectiveness of β-blockers in the Long QT Type 1 Syndrome(Arrhythmia-Basic : Molecular and Genetic : Basis (A) : FRS4)(Featured Research Session (English))
• ECG Findings in Andersen's Syndrome : Action Potential Simulation Study
• ECG Findings in Andersen's Syndrome : Action Potential Simulation Study
• NRSF Is Involved in Molecular Pathways for Sudden Death Associated with Heart Failure
• Hydroxyzine, a First Generation H_1-Receptor Antagonist, Inhibits Human Ether-a-go-go-Related Gene (HERG) Current and Causes Syncope in a Patient With the HERG Mutation
• PJ-571 Multiple Mechanisms underlie Long QT Syndrome by the Change of Amino Acid R259 in the Intracellular S4-S5 Linker of KCNQ1(PJ096,Arrhythmia, Others (Clinical/Pathophysiology) 4 (A),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The
• PE-106 SCN5A and Lamin A/C Gene Mutations are Highly Prevalent in Patients with Familial Bradyarrhythmic Disorders(PE018,Arrhythmia, Others (Clinical/Pathophysiology) (A),Poster Session (English),The 73rd Annual Scientific Meeting of The Japanese Circulat
• Association of Atrial Arrhythmia and Sinus Node Dysfunction in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia
• Whole-Body Periodic Acceleration Enhances Brachial Endothelial Function
• PJ-457 Chronic Effects of Angiotensin II Receptor Blockade on Coronary Fibrinolytic Function in Patients with Coronary Artery Disease(Coronary circulation, basic/clinical-3, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
• PJ-453 Effects of Chronic Smoking on Coronary Fibrinolytic Function in Women with Normal Coronary Arteries(Coronary circulation, basic/clinical-2, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
• Relationship between Metabolic Syndrome and Trp64Arg Polymorphism of the β3-Adrenergic Receptor Gene in a General Sample : The Shigaraki Study
• The Association between Morning Hypertension and Metabolic Syndrome in Hypertensive Patients
• Impact of Paraoxonase Polymorphism (Q192R) on Endothelial Function in Intact Coronary Circulation
• PJ-772 The Present Condition of the Morning Hypertension Patients after JSH2004(Hypertension, clinical-12 (H) PJ134,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)
• PJ-689 Relationship between a Metabolic Syndrome and the Polymorphism of the Beta3 Adrenergic Receptor Gene in a General Sample (S-town study)(Diabetes/Obesity/Metabolic syndrome-13 (H) PJ116,Poster Session (Japanese),The 70th Anniversary Annual Scientifi
• PJ-388 The Impact of Whole-body, Periodic Acceleration on Vascular Endothelial Function and Nitric Oxide Release(Exercise test/Cardiac rehabilitation-3 (IHD) PJ66,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Cir
• PJ-010 Aortic Stiffening Precedes Coronary Endothelial Dysfunction in Type II Diabetes Mellitus(Coronary circulation, basic/clinical-4 (IHD) PJ2,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)
• PJ-689 Relationship between a Metabolic Syndrome and the Polymorphism of the Beta3 Adrenergic Receptor Gene in a General Sample (S-town study)(Diabetes/Obesity/Metabolic syndrome-13 (H) PJ116,Poster Session (Japanese),The 70th Anniversary Annual Scientifi
• PJ-388 The Impact of Whole-body, Periodic Acceleration on Vascular Endothelial Function and Nitric Oxide Release(Exercise test/Cardiac rehabilitation-3 (IHD) PJ66,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Cir
• FRS-149 Mutation Site-Specific Differences in Arrhythmic Risk and Sensitivity to Sympathetic Stimulation in Japanese Families with Congenital LQT1 Syndrome(Sudden Cardiac Death (A) : FRS18)(Featured Research Session (English))
• 5 Genotype- and Mutation site-Specific Differences in Arrhythmic Risk and Sensitivity to Sympathetic Stimulation in the Long QT Syndrome(APSC/JCS Joint Symposium (APSC) (H) : Emerging Issue in Cardiology for Asian)(Special Program)
• ECG Findings in Andersen's Syndrome : Action Potential Simulation Study
• Novel Mutation of Plakophilin-2 Associated With Arrhythmogenic Right Ventricular Cardiomyopathy
• A novel SCN5A gain-of-function mutation M1875T associated with familial atrial fibrillation
• PJ-571 Multiple Mechanisms underlie Long QT Syndrome by the Change of Amino Acid R259 in the Intracellular S4-S5 Linker of KCNQ1(PJ096,Arrhythmia, Others (Clinical/Pathophysiology) 4 (A),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The
• PE-106 SCN5A and Lamin A/C Gene Mutations are Highly Prevalent in Patients with Familial Bradyarrhythmic Disorders(PE018,Arrhythmia, Others (Clinical/Pathophysiology) (A),Poster Session (English),The 73rd Annual Scientific Meeting of The Japanese Circulat
• Combined Analysis of Polymorphisms in Angiotensinogen and Adducin Genes and Their Effects on Hypertension in a Japanese Sample : The Shigaraki Study
• Change of Medication to Candesartan is Effective for Patients with Early Morning Surge in Blood Pressure (from the ATOM Study) (Hypertension, Clinical 10 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
• 1 Molecular Basis for Low Penetrance in the Long QT Syndrome(Meet the Expert 7 (ME7) (A) : Issues on Sudden Cardiac Death)(Special Program)
• Molecular and Genetic Basis for the Treatment of Long QT-Related Lethal Ventricular Arrhythmias
• Verapamil binding sites of K_ channel may reside on the cytosolic end of the TM2 of the pore-forming subunit, Kir6.2
• Why does intracoronary ACh injection induce torsade de pointes in long QT syndrome? : Role of Nitric Oxide
• Therapeutic concentrations of bepridil voltage-dependently block of IK_s reconstituted by KCNQ1/KCNE1
• LQT1, but not LQT2, patients show an exercise-induced increase in transmural dispersion of repolarization (TDR)
• Electrical Remodeling of the Ventricular Myocardium in Myocarditis : Studies of Rat Experimental Autoimmune Myocarditis
• OJ-012 Mutation Analysis for the Human Cardiac Ryanodine Receptor Gene (RyR2) in Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)(Arrhythmia, diagnosis/pathophysiology/EPS-03, The 71st Annual Scientific Meeting of the Japanese Circulation Soci
• PE-104 Severer Phenotypes of Long QT Syndrome are Associated with Compound Mutations : A Multicenter Study(PE018,Arrhythmia, Others (Clinical/Pathophysiology) (A),Poster Session (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Soci
• FRS-052 Identification and Functional Characterization of a Novel Intronic Splicing Mutation in KCNQ1 Associated with Long QT Syndrome(FRS11,New Insights into Basic Mechanisms of Arrhythmia (A),Featured Research Session (English),The 73rd Annual Scientifi
• 2 Latent Genetic Backgrounds and Molecular Pathogenesis of Drug-induced Long QT Syndrome(Proarrhythmic Risk of Drugs and Their Evaluation,Symposium 7 (SY-07) (I),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
• 1 A Novel Genetic Marker for Potential Risk of QT Prolongation and Cardiac Sudden Death : KCNE1-D85N Polymorphism(Biomarkers, Genetic Polymorphism, and Risk Estimation,Symposium 1 (SY-01) (H),The 73rd Annual Scientific Meeting of The Japanese Circulation
• Dynamic Change in ST-Segment and Spontaneous Occurrence of Ventricular Fibrillation in Brugada Syndrome With a Novel Nonsense Mutation in the SCN5A Gene During Long-Term Follow-up
• Mutation Analysis of the Glycerol-3 Phosphate Dehydrogenase-1 Like (GPD1L) Gene in Japanese Patients With Brugada Syndrome
• OE-219 Role of Bradykinin and Chymase in Cardiorenal Function under Chronic ACE Inhibition in Heart Failure(OE37,Kidney/Renal Circulation/CKD 1 (H),Oral Presentation (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
• PJ-306 ACE and Chymase Inhibition Prevents the Cardiac Remodeling Process Interacting with Cardiac Endothelin System in Heart Failure.(Heart failure, basic(06)(M),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Soci
• FRS-013 Chymase Inhibition Improves Cardiac Dysfunction through the Suppression of Excessive Oxidative Stress in Heart Failure(Cardiac Function "Ventricular Mechanics and Calcium Handling", The 71st Annual Scientific Meeting of the Japanese Circulation So
• Cardiac Mast Cell Chymase Plays a Significant Role in the Progression of Cardiac Remodeling via Collagen Accumulation(Inflammatory Heart Disease-Update and Future Perspective-, The 69th Annual Scientific Meeting of the Japanese Circulation Society)
• Rationale for the Use of Combination Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Therapy in Heart Failure
• Long-term effect of efonidipine therapy on plasma aldosterone and left ventricular mass index in patients with essential hypertension
• PJ-641 Comparison of Serum Levels of Cardiac Tropnin I and T in Patients with Chronic Heart Failure(PJ108,Heart Failure (Laboratory/Biomarkers) 1 (M),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
• PJ-371 Effect of Carperitide on Plasma Adiponectin Level in Heart Failure Patients with Diabetes Mellitus(PJ063,Heart Failure (Treatment) 1 (M),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
• OJ-245 Effect of Carvedilol on Plasma Adiponectin Level in Patients with Chronic Heart Failure(OJ41,Heart Failure (Treatment) (M),Oral Presentation (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
• OJ-244 Effect of Carvedilol on Transcardiac Gradient of Norepinephrine and Prognosis in Patients with Chronic Heart Failure(OJ41,Heart Failure (Treatment) (M),Oral Presentation (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Soci
• FRS-025 Comparison with Serum Cortisol Level and Plasma Aldosterone Level as a Predictor of Cardiac Event in Patients with Heart Failure(FRS5,Novel Biomarkers in Heart Failure (M),Featured Research Session (English),The 73rd Annual Scientific Meeting of T
• Beneficial Effect of Perindopril on Cardiac Sympathetic Nerve Activity and Brain Natriuretic Peptide in Patients With Chronic Heart Failure : Comparison With Enalapril
• PJ-512 Impact of Oxidative Stress on Plasma Adiponectin in Patients with Heart Failure(Heart failure, clinical(18)(M),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
• Comparison of the Effects of Efonidipine and Amlodipine on Aldosterone in Patients with Hypertension
• Effects of Carperitide on the Long-Term Prognosis of Patients With Acute Decompensated Chronic Heart Failure : The PROTECT Multicenter Randomized Controlled Study
• PJ-199 Effects of Carperitide on Cardiorenal Protection and Prognosis in Patients with Acute Decompensated Heart Failure; PROTECT Study(Heart failure, clinical-11 (M) PJ34,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meeting of the Jap
• PE-472 Effects of Carperitide Treatment on Cardio-Renal Biomarkers in Patients with Acute Decompensated Heart Failure : sub-analyses of the PROTECT Study(Heart failure, clinical-7 (M) PE79,Poster Session (English),The 70th Anniversary Annual Scientific Me
• Assessment of cardiac function in patients with heart disease by quantitative gated myocardial perfusion SPECT
• PE-362 A Novel Clinical Indicator Using Tc-99m Sestamibi for Evaluating Cardiac Mitochondrial Function in Patients with Cardiomyopathies(Nuclear cardiology-5, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
• Myocardial Creatine Concentration in Various Nonischemic Heart Diseases Assessed by ^1H Magnetic Resonance Spectroscopy
• OE-136 NADPH Oxidase Inhibition Improves Cardiac Dysfunction through the Suppression of Oxidative Stress And the Renin-Angiotensin System in Heart Failure(Cardiac function, basic/clinical(01)(M),Oral Presentation(English),The 72nd Annual Scientific Meetin
• Proteome Analysis Reveals the Significant Alternations of Cardiac Small Heat Shock Proteins Expression in Heart Failure (Heart Failure, Basic 6 (M), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
• Chronic NADPH Oxidase Inhibiton Improves Cardiac Function through the Suppression of Oxidative Stress in Heart Failure(Cardiovascular Pharmacology, Basic/Clinical 2 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
• Contribution of Vascular NAD(P)H Oxidase to Endothelial Dysfunction in Heart Failure and the Therapeutic Effects of HMG-CoA Reductase Inhibitor
• PJ-509 Transcardiac Difference of Aldosterone in Patients with Heart Disease(Heart Failure, Clinical 13 (M) : PJ85)(Poster Session (Japanese))
• PJ-418 Relationship Between Transcardiac Increase of C-Reactive Protein and Transcardiac Increase of Interleukin-6 in Patients with Dilated Cardiomyopathy(Cardiomyopathy, Clinical 4 (M) : PJ70)(Poster Session (Japanese))
• PJ-224 The Activity and Expression of Myocardial NADPH Oxidase Are Increased in Heart Failure.(Heart Failure, Basic 2 (M) : PJ38)(Poster Session (Japanese))
• OJ-440 Proteome analysis of myocardial protein expression in heart failure(Heart Failure, Basic 3 (M) : OJ54)(Oral Presentation (Japanese))
• OJ-225 Relationship Between Heart-type Fatty Acid-binding Protein and Left Ventricular Remodeling in Patients with Dilated Cardiomyopathy(Cardiomyopathy, Clinical 1 (M) : OJ26)(Oral Presentation (Japanese))
• FRS-191 Comparison of BMP and N terminal proBNP in Patients with Heart Failure(Heart Failure : Basic and Clinical Viewpoint (M) : FRS22)(Featured Research Session (English))
• Neurohumoral Effects of Long Term Infusion of hANP in Patients with Severe Congestive Heart Failure
• OE-146 Aldosterone Blocker Spironolactone Prevents Post-infarct Ventricular Late Remodeling in Patients with First Anterior Acute Myocardial Infarction(Acute Myocardial Infarction, Clinical (Diagnosis/Treatment) 5 (IHD) : OE18)(Oral Presentation (English)
• PJ-634 Plasma High-Molecular Weight Adiponectin in Patients with Chronic Heart Failure(Heart failure, clinical-17, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
• PJ-633 Possible Contribution of Oxidative Stress and BNP on the Elevation of Adiponectin in Patients with Chronic Heart Failure(Heart failure, clinical-17, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
• In Vivo Vasodilatory Action of Atrial Natriuretic Peptides in Canine Coronary Circulation
• OE-320 Angiotensin II Receptor Blocker with Spironolactone is more Beneficial on Cardiac Protection than with Thiazide in Patients with Essential Hypertension(Hypertension, clinical-2 (H) OE54,Oral Presentation (English),The 70th Anniversary Annual Scient
• PE-291 Long-acting diuretics has a beneficial effects of neurohumoral factors in patients with mild congestive heart failure(Heart Failure, Clinical 11 (M) : PE50)(Poster Session (English))
• Transcardiac Gradient of Plasma Heart-Type Fatty Acid Binding Protein as a Maker of Myocardial Injury in Patients with Dilated Cardiomyopathy
• OJ-198 Atorvastatin Improves Cardiac Sympathetic Nerve Activity in Patients with Heart Failure(Heart failure, clinical(06)(M),Oral Presentation (Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
• PJ-405 Proteome Analysis Reveals the Therapeutic Effects of Carvedilol on Myocardial Protein Expression in Heart Failure(Heart failure, basic-5 (M) PJ68,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation S
• OJ-050 Comparative Effect of Metoprolol and Carvedilol on Myocardial Oxidative Stress in Patients with Chronic Heart Failure(Heart failure, clinical-2 (M) OJ9,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Circ
• Slightly Renal Dysfunction Influences on the Plsama N terminal proBNP Level in Patient with Heart Failure(Heart Failure, Clinical 13 (M), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
• Endogenous Bradykinin Suppresses Myocardial Fibrosis through the Cardiac Generated Endothelin System under Chronic ACE Inhibition in Heart Failure
• Relationship between Plasma Level of Cardiotrophin-1 and Prognosis in Patients with Dilated Cardiomyopathy
• Plasma NT-proBNP as a More Reliable Biomarker of Endogenous Cardiac Natriuretic Peptides Than BNP During Carperitide Infusion
• Serum Level of Uric Acid, Partly Secreted From the Failing Heart, is a Prognostic Marker in Patients With Congestive Heart Failure
• Prediction of Mortality by High-Sensitivity C-Reactive Protein and Brain Natriuretic Peptide in Patients With Dilated Cardiomyopathy
• PJ-782 Plasma N-terminal proBNP Level is More Sensitive Marker of Myocardial Ischemia Than BNP(Neurohumoral factors-3 (H) PJ137,Poster Session (Japanese),Poster Session (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation
• PJ-062 Carperitide and Renal Function in Patients with Chronic Heart Failure(Heart failure, clinical-19 (M) PJ11,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)
• OJ-162 Myocardial Ischemia Itself Increases the Secretion of N-terminal proBNP from the Heart Independent of Hemodynamic Overload(Chronic coronary heart disease/Remodeling-2 (IHD) OJ27,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific Me
• OJ-108 Prognostic Value of Combination of Serum Uric Acid and Brain Natriuretic Peptide in Patients with Chronic Heart Failure(Heart failure, clinical-4 (M) OJ18,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese C
• OJ-107 Plasma Active Renin Concentration is an Independent Prognostic Predictor in Patients with Chronic Heart Failure(Heart failure, clinical-4 (M) OJ18,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulati
• Is Transcardiac Increase of plasma N-terminal proBNP Level Related to Coronary Artery Stenosis in Patients with Ischemic Heart Disease? (Neurohumoral Factors 4 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
• Plasma High-Sensitive C-Reactive Protein as an Independent Prognostic Predictor in Patients with Dilated Cardiomyopathy(Cardiomyopathy, Clinical 8 (M), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
• Inhibition of Aldosterone and Endothelin-1 by Carperitide was Attenuated More Than One Week Infusion in Patients with Congestive Heart Failure(Heart Failure, Clinical 14 (M), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
• OE-184 Plasma C-Reactive Protein as an Independent Prognostic Predictor in Patients with Dilated Cardiomyopathy(Heart Failure, Clinical 2 (M) : OE23)(Oral Presentation (English))

もっと見る 閉じる

スポンサーリンク